Model
Edge
Acrivon Therapeutics Inc.
0002013475
Filing Type
3
Filing Date
3/5/2024
Updated
3/6/24, 9:29 AM
Filing
3
Earnings Release
Exhibits
3
Initial Statement of Beneficial Ownership